Robert Wessman to speak at UBS pharmaceuticals conference
The CEO of Actavis generic pharmaceuticals, Robert Wessman, is scheduled to speak at the annual UBS Global Specialty and Generic Pharmaceuticals Confe...
The CEO of Actavis generic pharmaceuticals, Robert Wessman, is scheduled to speak at the annual UBS Global Specialty and Generic Pharmaceuticals Confe...